S186 - CAS 97759-16-5
Catalog number: 97759-16-5
Category: Inhibitor
Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Molecular Formula:
C5H13CaNNaO7P2+3
Molecular Weight:
324.17
COA:
Inquire
Targets:
Others
Description:
S186 is a kind of sodium salts of calcium-acetylpropylamine phosphonate(APA). It is a new strontium-specific chelating agent. It has also been approved by Shanghai Municipal Health Bureau for emergency medical use in China.
Purity:
>98%
Synonyms:
S186; S 186; S-186
MSDS:
Inquire
InChIKey:
WPTHTLCSASTWJP-UHFFFAOYSA-N
InChI:
InChI=1S/C5H13NO7P2.Ca.Na/c1-3-5(6-4(2)7,14(8,9)10)15(11,12)13;;/h3H2,1-2H3,(H,6,7)(H2,8,9,10)(H2,11,12,13);;
Canonical SMILES:
CCC(NC(=O)C)(P(=O)(O)O)P(=O)(O)O.[Na].[Ca]
1.Amino acid substitutions reveal distinct functions of serine 186 of the ZEBRA protein in activation of early lytic cycle genes and synergy with the Epstein-Barr virus R transactivator.
Francis A;Ragoczy T;Gradoville L;Heston L;El-Guindy A;Endo Y;Miller G J Virol. 1999 Jun;73(6):4543-51.
The ZEBRA protein mediates the switch between the latent and lytic life cycles of Epstein-Barr virus. Z(S186A), a point mutant in ZEBRA's basic domain in which serine 186 is changed to alanine, is unable to induce expression of lytic cycle mRNAs or proteins from the latent EBV genome even though it retains the ability to activate transcription from reporters bearing known ZEBRA-responsive promoters (A. L. Francis et al., J. Virol. 71:3054-3061, 1997). We now describe three distinct phenotypes of ZEBRA mutants bearing different amino acid substitutions at S186. These phenotypes are based on the capacity of the mutants to activate expression of the BRLF1 and BMRF1 genes, which are targets of ZEBRA's action, and to synergize with the BRLF1 gene product Rta (R transactivator) in activating expression of downstream genes. One mutant class, represented by Z(S186T), was similar to the wild type, although reduced in the capacity to activate BRLF1 and BMRF1 early lytic cycle genes from the latent virus. A second class, represented by Z(S186C) and Z(S186G), was impaired in transcriptional activation, unable to activate early lytic cycle products from the latent virus, and not rescued by overexpression of Rta.
2.Identification of a major phosphopeptide in human tristetraprolin by phosphopeptide mapping and mass spectrometry.
Cao H;Deterding LJ;Blackshear PJ PLoS One. 2014 Jul 10;9(7):e100977. doi: 10.1371/journal.pone.0100977. eCollection 2014.
Tristetraprolin/zinc finger protein 36 (TTP/ZFP36) binds and destabilizes some pro-inflammatory cytokine mRNAs. TTP-deficient mice develop a profound inflammatory syndrome due to excessive production of pro-inflammatory cytokines. TTP expression is induced by various factors including insulin and extracts from cinnamon and green tea. TTP is highly phosphorylated in vivo and is a substrate for several protein kinases. Multiple phosphorylation sites are identified in human TTP, but it is difficult to assign major vs. minor phosphorylation sites. This study aimed to generate additional information on TTP phosphorylation using phosphopeptide mapping and mass spectrometry (MS). Wild-type and site-directed mutant TTP proteins were expressed in transfected human cells followed by in vivo radiolabeling with [32P]-orthophosphate. Histidine-tagged TTP proteins were purified with Ni-NTA affinity beads and digested with trypsin and lysyl endopeptidase. The digested peptides were separated by C18 column with high performance liquid chromatography. Wild-type and all mutant TTP proteins were localized in the cytosol, phosphorylated extensively in vivo and capable of binding to ARE-containing RNA probes.
3.Phosphorylation of the nuclear form of varicella-zoster virus immediate-early protein 63 by casein kinase II at serine 186.
Mueller NH;Graf LL;Orlicky D;Gilden D;Cohrs RJ J Virol. 2009 Dec;83(23):12094-100. doi: 10.1128/JVI.01526-09. Epub 2009 Sep 16.
Varicella-zoster virus (VZV) open reading frame (ORF) 63 is abundantly transcribed in latently infected human ganglia and encodes a 278-amino-acid protein, IE63, with immediate-early kinetics. IE63 is expressed in the cytoplasm of neurons during VZV latency and in both the cytoplasm and the nucleus during productive infection; however, the mechanism(s) involved in IE63 nuclear import and retention has remained unclear. We constructed and identified a recombinant monoclonal antibody to detect a posttranslationally modified form of IE63. Analysis of a series of IE63 truncation and substitution mutants showed that amino acids 186 to 195 are required for antibody binding. Synthetic peptides corresponding to this region identified IE63 S186 as a target for casein kinase II phosphorylation. In addition, acidic charges supplied by E194 and E195 were required for antibody binding. Immunofluorescence analysis of VZV-infected MeWo cells using the recombinant monoclonal antibody detected IE63 exclusively in the nuclei of infected cells, indicating that casein kinase II phosphorylation of S186 occurs in the nucleus and possibly identifying an initial molecular event operative in VZV reactivation.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Products


GYKI-16638 HCl
(CAS: 307556-59-8)

GYKI-16638 is a novel antiarrhythmic agent, shows combined Class IB and Class III antiarrhythmic properties, resembling the electrophysiological manifestation s...

CAS 23233-88-7 Brotianide

Brotianide
(CAS: 23233-88-7)

Brotianide, with anti-fasciolidal activity, is an anthelminthic drug for the treatment of severe infections on animals to remove larvae.

MI 2 dihydrochloride

MI 2 dihydrochloride is a Menin-MLL interaction inhibitor. MI-2 can bind menin and block the menin-MLL fusion protein interaction with IC50 value of 0.45 μM. It...

CAS 68506-86-5 Vigabatrin

Vigabatrin
(CAS: 68506-86-5)

Vigabatrin is a structural analog of the inhibitory neurotransmitter γ-aminobutyric acid (GABA) that irreversibly inhibits the catabolism of GABA by GABA transa...

MK-0493
(CAS: 455957-71-8)

MK-0493 is a novel, potent, and selective agonist of MC4R( melanocortin receptor 4) , which is one of the best-validated genetic targets and considered one of t...

CAS 740980-24-9 ACV 1

ACV 1
(CAS: 740980-24-9)

ACV 1 has been found to be a neuronal nicotinic receptor antagonist and could probably alleviate neuropathic pain.

CAS 88519-57-7 W-13 hydrochloride

W-13 hydrochloride
(CAS: 88519-57-7)

W-13 hydrochloride is a calmodulin antagonist that inhibits calmodulin activated PDE activity with an IC50 of 68 μM.

20-O-Acetylingenol-3-angelate
(CAS: 82425-35-2)

20-O-Acetylingenol-3-angelate is a natural compound extracted from Euphorbia conspicua N. E. Br. It is used as molluscicidal agent, anti-cancer agent and cytost...

Chemical Structure

CAS 97759-16-5 S186

Quick Inquiry

Verification code

Featured Items